Long-acting buprenorphine
A long-acting formulation of an opioid agonist treatment, which is used to reduce opioid cravings and could help reduce behaviors that contribute to the transmission of hepatitis C and other blood-borne diseases.
Self-tests for hepatitis C
Fast, reliable self-test results ensure more people access treatment.
Low dead space syringes
Reduces the risk of transmitting blood-borne infections like hepatitis C, as well as hepatitis B and HIV, when needles are shared.
Unitaid ready to invest immediately to support accelerated global access to lenacapavir
Unitaid renews call for clear access strategy after positive results from Gilead’s PURPOSE 2 lenacapavir trial
AFRAVIH 2024
Unitaid is proud to be a key partner of AFRAVIH 2024, a major HIV conference taking place in Yaoundé, Cameroon. This event gathers experts and stakeholders from around the world to discuss advances and strategies in the fight against HIV/AIDS.
Join us at AFRAVIH 2024 as we explore transformative strategies and innovative partnerships in the global fight against HIV and its co-infections. Don’t miss the opportunity to engage with leading experts and be part of crucial discussions that shape the future of global health.